SYNTHETIC BLOOD INTERNATIONAL INC
10-Q, EX-27.1, 2000-12-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SYNTHETIC BLOOD INTERNATIONAL INC, 10-Q, 2000-12-14
Next: FIRST HARTFORD CORP, 10-Q, 2000-12-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SECOND
QUARTER ENDED OCTOBER 31, 2000 SYNTHETIC BLOOD INTERNATIONAL, INC.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          APR-30-2001
<PERIOD-START>                             MAY-01-2000
<PERIOD-END>                               OCT-31-2000
<CASH>                                       5,099,191
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             5,142,667
<PP&E>                                         238,087
<DEPRECIATION>                                  58,409
<TOTAL-ASSETS>                               5,553,046
<CURRENT-LIABILITIES>                          296,633
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       873,534
<OTHER-SE>                                   4,382,879
<TOTAL-LIABILITY-AND-EQUITY>                 5,553,046
<SALES>                                              0
<TOTAL-REVENUES>                               182,268
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               943,331
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,070
<INCOME-PRETAX>                              (762,133)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (762,133)
<EPS-BASIC>                                   ($0.009)
<EPS-DILUTED>                                 ($0.009)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission